牛叉诊股

[{"date":"2025.11.05","stock":"-0.91","trade":"0.46","ind":"0.37"},{"date":"2025.11.04","stock":"-2.23","trade":"-0.65","ind":"-1.71"},{"date":"2025.11.03","stock":"4.50","trade":"0.77","ind":"0.19"},{"date":"2025.10.31","stock":"10.02","trade":"2.11","ind":"-1.14"},{"date":"2025.10.30","stock":"-1.62","trade":"-1.13","ind":"-1.16"},{"date":"2025.10.29","stock":"1.54","trade":"-0.32","ind":"1.95"},{"date":"2025.10.28","stock":"-2.50","trade":"-0.54","ind":"-0.44"},{"date":"2025.10.27","stock":"0.39","trade":"-0.12","ind":"1.51"},{"date":"2025.10.24","stock":"-2.55","trade":"-0.63","ind":"2.02"},{"date":"2025.10.23","stock":"-4.75","trade":"-0.36","ind":"0.22"},{"date":"2025.10.22","stock":"5.22","trade":"0.70","ind":"-0.62"},{"date":"2025.10.21","stock":"1.04","trade":"0.86","ind":"2.06"},{"date":"2025.10.20","stock":"4.30","trade":"0.20","ind":"0.98"},{"date":"2025.10.17","stock":"2.11","trade":"-0.94","ind":"-3.04"},{"date":"2025.10.16","stock":"-0.75","trade":"0.75","ind":"-0.25"},{"date":"2025.10.15","stock":"3.99","trade":"1.37","ind":"1.73"},{"date":"2025.10.14","stock":"-1.02","trade":"0.32","ind":"-2.54"},{"date":"2025.10.13","stock":"-1.41","trade":"-0.86","ind":"-0.93"},{"date":"2025.10.10","stock":"0.06","trade":"1.31","ind":"-2.70"},{"date":"2025.10.09","stock":"-1.85","trade":"0.26","ind":"1.47"},{"date":"2025.09.30","stock":"1.83","trade":"0.12","ind":"0.35"}]

众生药业,深证成指,中药指数

压力支撑

该股压力位为19.72元，支撑位为19.14元。

[{"text":"\u538b\u529b\u4f4d","value":"19.72","date":1762272000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.14","date":1762272000,"color":"0x0b52a1"}]

多空趋势

多头行情中，并且有加速上涨趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.6资金面打败了84%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体无进出。

更新时间：11月05日 20:30

机构今日流向(万元)	-58.92	机构5日流向(万元)	-866.37
机构10日流向(万元)	-8700.82	机构20日流向(万元)	-7315.64

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量减少2269.28万股，其中基金净减仓12家，主力净减仓29家，请投资者中长期谨慎为宜。

截止2025-06-30，共95家主力机构（基金93家，一般法人1家，社保基金1家），持仓量总计8147.07万股，占流通A股10.70%
其中，基金持仓与2024-12-31相比：
增仓：14家，增持 551.72万股
减仓：26家，减持 1539.85万股
新出现在主力名单中：47家，持有2194.43万股
从主力名单中消失：76家，原持有3033.8万股

消息面诊股

诊断结果：5.8消息面打败了16%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向		2025-09-18
一般消息	分红转增	不分配不转增	2025-08-29
一般消息	股东大会	临时股东大会	2025-08-01
一般消息	募资投向	公司购买资产	2025-08-01
一般消息	重大事项	关联交易	2025-08-01
重大利好	业绩预告	业绩大幅上升	2025-07-15
一般消息	重大事项	关联交易	2025-06-25
利好	分红转增	10派2元(含税)	2025-04-26
一般消息	重大事项	公司股东股份解押	2025-04-11
一般消息	募资投向	公司购买资产	2025-04-01
一般消息	重大事项	关联交易	2025-04-01
一般消息	募资投向	公司购买资产	2025-03-27
一般消息	重大事项	关联交易	2025-03-27
一般消息	重大事项	公司股东股份解押	2025-03-27
利空	业绩预告	业绩预亏	2025-01-25
一般消息	重大事项	关联交易	2024-12-24

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	1条	1条
利空	1条	0条	1条

行业面诊股

诊断结果：6.0行业面打败了70%的股票中药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2025.11.05","price":"0.37","value":"0.46"},{"date":"2025.11.04","price":"-1.71","value":"-0.65"},{"date":"2025.11.03","price":"0.19","value":"0.77"},{"date":"2025.10.31","price":"-1.14","value":"2.11"},{"date":"2025.10.30","price":"-1.16","value":"-1.13"},{"date":"2025.10.29","price":"1.95","value":"-0.32"},{"date":"2025.10.28","price":"-0.44","value":"-0.54"},{"date":"2025.10.27","price":"1.51","value":"-0.12"},{"date":"2025.10.24","price":"2.02","value":"-0.63"},{"date":"2025.10.23","price":"0.22","value":"-0.36"},{"date":"2025.10.22","price":"-0.62","value":"0.70"},{"date":"2025.10.21","price":"2.06","value":"0.86"},{"date":"2025.10.20","price":"0.98","value":"0.20"},{"date":"2025.10.17","price":"-3.04","value":"-0.94"},{"date":"2025.10.16","price":"-0.25","value":"0.75"},{"date":"2025.10.15","price":"1.73","value":"1.37"},{"date":"2025.10.14","price":"-2.54","value":"0.32"},{"date":"2025.10.13","price":"-0.93","value":"-0.86"},{"date":"2025.10.10","price":"-2.70","value":"1.31"},{"date":"2025.10.09","price":"1.47","value":"0.26"},{"date":"2025.09.30","price":"0.35","value":"0.12"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	特一药业	37.51%	10.24%	6.8分
2	万邦德	18.93%	-5.87%	4.5分
3	维康药业	18.14%	14.06%	5.6分
4	以岭药业	13.79%	-0.34%	6.1分
5	众生药业	13.19%	9.58%	6.3分
6	贵州百灵	12.76%	0.51%	5.3分
7	粤万年青	12.03%	3.02%	5.4分
8	ST葫芦娃	12.00%	8.92%	5.7分
9	康恩贝	9.66%	4.61%	7.0分
10	马应龙	8.51%	5.48%	5.7分
11	华神科技	7.63%	4.07%	6.1分
12	精华制药	7.13%	2.96%	6.3分
13	达仁堂	6.90%	10.25%	6.3分
14	益盛药业	6.68%	3.10%	5.8分
15	盘龙药业	6.50%	3.05%	5.8分
16	嘉应制药	6.14%	2.18%	6.0分
17	益佰制药	6.13%	2.85%	6.0分
18	佛慈制药	6.04%	2.01%	5.5分
19	金花股份	5.80%	4.25%	6.4分
20	-	5.75%	2.50%	分
21	吉林敖东	5.50%	-4.22%	5.4分
22	振东制药	5.03%	0.88%	4.7分
23	陇神戎发	4.94%	1.90%	5.4分
24	亚宝药业	4.43%	2.09%	5.9分
25	华润三九	4.41%	0.24%	5.2分
26	新光药业	4.41%	1.68%	5.2分
27	桂林三金	4.39%	0.46%	6.0分
28	千金药业	4.36%	3.26%	6.5分
29	上海凯宝	4.28%	2.59%	6.1分
30	白云山	3.95%	1.68%	6.7分
31	仁和药业	3.81%	1.46%	5.9分
32	红日药业	3.79%	1.59%	5.6分
33	九芝堂	3.60%	1.21%	5.6分
34	济川药业	3.54%	1.33%	5.3分
35	汉森制药	3.46%	3.79%	5.4分
36	珍宝岛	3.24%	1.87%	3.7分
37	广誉远	3.17%	2.46%	6.5分
38	新天药业	3.09%	3.77%	5.7分
39	康美药业	2.97%	2.46%	6.3分
40	太龙药业	2.93%	3.89%	6.1分
41	中恒集团	2.93%	1.44%	5.5分
42	天目药业	2.41%	-1.16%	5.5分
43	康惠股份	2.27%	2.83%	4.9分
44	信邦制药	2.11%	1.04%	5.5分
45	羚锐制药	1.23%	-3.65%	5.2分
46	东阿阿胶	1.18%	1.25%	5.6分
47	-	1.05%	0.15%	分
48	启迪药业	0.61%	-5.79%	4.7分
49	华森制药	-0.12%	0.25%	5.1分
50	沃华医药	-0.32%	0.48%	5.6分
51	康缘药业	-0.33%	3.03%	5.5分
52	寿仙谷	-0.78%	0.10%	4.7分
53	江中药业	-0.98%	-0.79%	5.0分
54	同仁堂	-1.41%	-0.92%	4.9分
55	云南白药	-1.55%	-0.85%	5.5分
56	方盛制药	-1.67%	-6.59%	5.0分
57	健民集团	-2.28%	0.43%	5.1分
58	天士力	-2.82%	-1.75%	5.4分
59	ST香雪	-2.83%	1.63%	4.0分
60	昆药集团	-3.22%	-0.81%	4.2分
61	奇正藏药	-3.47%	-0.20%	5.4分
62	佐力药业	-3.60%	-1.44%	4.4分
63	恩威医药	-4.03%	-2.73%	4.6分
64	贵州三力	-4.03%	0.83%	4.7分
65	步长制药	-4.70%	-4.86%	5.1分
66	葵花药业	-5.24%	-0.82%	3.8分
67	太极集团	-5.58%	-1.67%	4.7分
68	*ST长药	-9.04%	5.71%	3.3分
69	片仔癀	-10.79%	-1.83%	4.4分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：7.0基本面打败了88%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（72.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 27/109 ， 30/109。

[{"date":"2025-09-30","value":"6.31","vol":"4.74"},{"date":"2025-06-30","value":"4.78","vol":"3.98"},{"date":"2025-03-31","value":"2.09","vol":"2.21"},{"date":"2024-12-31","value":"-7.23","vol":"4.80"},{"date":"2024-09-30","value":"3.40","vol":"2.91"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	6.31	4.78	2.09	-7.23	3.40
行业(%)	4.74	3.98	2.21	4.80	2.91

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"56.80","vol":"52.31"},{"date":"2025-06-30","value":"58.07","vol":"52.86"},{"date":"2025-03-31","value":"56.58","vol":"53.38"},{"date":"2024-12-31","value":"56.03","vol":"52.74"},{"date":"2024-09-30","value":"56.08","vol":"53.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	56.80	58.07	56.58	56.03	56.08
行业(%)	52.31	52.86	53.38	52.74	53.11

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 27/109 ， 12/109。

[{"date":"2025-09-30","value":"-1.01","vol":"-7.31"},{"date":"2025-06-30","value":"-4.74","vol":"-7.31"},{"date":"2025-03-31","value":"-1.07","vol":"-7.18"},{"date":"2024-12-31","value":"-5.48","vol":"-7.35"},{"date":"2024-09-30","value":"-7.88","vol":"-5.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-1.01	-4.74	-1.07	-5.48	-7.88
行业(%)	-7.31	-7.31	-7.18	-7.35	-5.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"68.40","vol":"-2.54"},{"date":"2025-06-30","value":"114.96","vol":"2.98"},{"date":"2025-03-31","value":"61.06","vol":"-37.19"},{"date":"2024-12-31","value":"-213.63","vol":"-146.29"},{"date":"2024-09-30","value":"-46.76","vol":"61.78"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	68.40	114.96	61.06	-213.63	-46.76
行业(%)	-2.54	2.98	-37.19	-146.29	61.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 33/109 ， 17/109。

[{"date":"2025-09-30","value":"0.35","vol":"0.35"},{"date":"2025-06-30","value":"0.24","vol":"0.24"},{"date":"2025-03-31","value":"0.12","vol":"0.12"},{"date":"2024-12-31","value":"0.41","vol":"0.50"},{"date":"2024-09-30","value":"0.31","vol":"0.37"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.35	0.24	0.12	0.41	0.31
行业(次)	0.35	0.24	0.12	0.50	0.37

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"2.06","vol":"1.73"},{"date":"2025-06-30","value":"1.36","vol":"1.18"},{"date":"2025-03-31","value":"0.67","vol":"0.61"},{"date":"2024-12-31","value":"2.26","vol":"2.42"},{"date":"2024-09-30","value":"1.67","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	2.06	1.36	0.67	2.26	1.67
行业(次)	1.73	1.18	0.61	2.42	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"19.58","vol":"9.48"},{"date":"2025-06-30","value":"10.26","vol":"20.05"},{"date":"2025-03-31","value":"-4.51","vol":"-0.23"},{"date":"2024-12-31","value":"6.68","vol":"15.64"},{"date":"2024-09-30","value":"16.15","vol":"5.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	19.58	10.26	-4.51	6.68	16.15
行业	9.48	20.05	-0.23	15.64	5.86

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.81","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.79","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	1.81	-	1.79	-
行业	0.00	1.02	0.00	1.45	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 48/109 ， 52/109。

[{"date":"2025-09-30","value":"3.73","vol":"3.05"},{"date":"2025-06-30","value":"3.54","vol":"2.90"},{"date":"2025-03-31","value":"3.92","vol":"2.99"},{"date":"2024-12-31","value":"2.88","vol":"2.88"},{"date":"2024-09-30","value":"7.79","vol":"3.25"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	3.73	3.54	3.92	2.88	7.79
行业	3.05	2.90	2.99	2.88	3.25

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"3.01","vol":"2.21"},{"date":"2025-06-30","value":"2.78","vol":"2.13"},{"date":"2025-03-31","value":"3.06","vol":"2.22"},{"date":"2024-12-31","value":"2.26","vol":"2.11"},{"date":"2024-09-30","value":"5.80","vol":"2.43"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	3.01	2.78	3.06	2.26	5.80
行业	2.21	2.13	2.22	2.11	2.43

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 45/109 ， 46/109。

[{"date":"2025-09-30","value":"20.16","vol":"33.12"},{"date":"2025-06-30","value":"21.52","vol":"33.87"},{"date":"2025-03-31","value":"21.76","vol":"33.29"},{"date":"2024-12-31","value":"27.79","vol":"34.05"},{"date":"2024-09-30","value":"21.94","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	20.16	21.52	21.76	27.79	21.94
行业(%)	33.12	33.87	33.29	34.05	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.26","vol":"0.75"},{"date":"2025-06-30","value":"0.28","vol":"0.74"},{"date":"2025-03-31","value":"0.29","vol":"0.72"},{"date":"2024-12-31","value":"0.39","vol":"0.75"},{"date":"2024-09-30","value":"0.29","vol":"3.20"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.26	0.28	0.29	0.39	0.29
行业(%)	0.75	0.74	0.72	0.75	3.20

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
东海证券	2025-11-04	买入	买入
国盛证券	2025-09-15	买入	买入
甬兴证券	2025-09-08	买入
广发证券	2025-09-05	买入
开源证券	2025-08-29	买入
华鑫证券	2025-08-24	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"2.78","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.22","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.63","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-2.99","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"3.27","blueLineValue":"0.38","type":"YC"}]

[众生药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]